Submission of documents under regulation 33 of SEBI (LODR), Regulation, 2015, for the quarter ended 31.12.2024.
Awaiting price reaction for this filing.
Lords Chemicals Ltd reported its Q3 FY25 (quarter ended 31 Dec 2024) and nine-month results, showing a sharp deterioration in operations. Revenue from operations fell to Rs. 10.83 lakhs in Q3 FY25 from Rs. 22.91 lakhs in Q3 FY24, a drop of roughly 53%, while nine-month revenue declined to Rs. 38.97 lakhs from Rs. 48.13 lakhs. The company posted a loss before tax of Rs. 6.29 lakhs in Q3 and Rs. 55.12 lakhs for the nine months, against Rs. 6.28 lakhs and Rs. 19.85 lakhs a year ago. The statutory auditor (Rajesh Jalan & Associates) issued a qualified conclusion, flagging an eroded net worth, going concern doubts, negative operating cash flows, unrecovered related-party advances of around Rs. 8.52 crore, and outstanding statutory dues of about Rs. 1.60 crore. Audits for FY23 and FY24 were only completed in June 2025, well after the reporting period, and the Company Secretary post remained vacant until May 2025.
This is a deeply negative disclosure for shareholders — the company is loss-making, its net worth is wiped out, the auditor has qualified the results citing going concern uncertainty, and large related-party advances and statutory dues remain unreconciled. The stock is likely to remain under heavy pressure and may attract further regulatory scrutiny given the pattern of delayed filings and non-compliance with listing rules.